When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...
Key Insights Given the large stake in the stock by institutions, Genetic Signatures' stock price might be vulnerable to...
Genetic Signatures Limited [ASX:GSS] ("GSS" or the "Company"), a global molecular diagnostics company announces that the US Food & Drug Administration ("FDA") has cleared the Company's EasyScreen™ Gastrointestinal Parasite Detection Kit and GS1 automated workflow[1] for marketing and sale in the US.